DIFFERENTIATED THYROID CANCER
Clinical trials for DIFFERENTIATED THYROID CANCER explained in plain language.
Never miss a new study
Get alerted when new DIFFERENTIATED THYROID CANCER trials appear
Sign up with your email to follow new studies for DIFFERENTIATED THYROID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat thyroid cancer? drug trial shows promise
Disease control CompletedThis trial tested a new drug called AL2846 in 33 people with a type of thyroid cancer that no longer responds to standard treatments. The goal was to see if the drug could shrink tumors or slow the cancer's growth. Participants took the drug by mouth, and researchers measured how…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Minutes vs. days: new rapid test could speed up thyroid cancer detection
Diagnosis CompletedThis study tested a new rapid test (POC-Tg) that measures thyroglobulin levels in fluid from a lymph node biopsy to quickly detect if thyroid cancer has spread. Currently, patients wait days to weeks for results. The new test aims to give results in minutes, helping doctors make …
Matched conditions: DIFFERENTIATED THYROID CANCER
Sponsor: Soroka University Medical Center • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
New hope for tough thyroid cancers? study tests cabozantinib and searches for clues in the blood
Knowledge-focused CompletedThis study tested the drug cabozantinib in 41 adults with advanced thyroid cancer that stopped responding to radioactive iodine. The main goal was to find genetic markers in the blood that might predict how well the drug works. Researchers also tracked tumor shrinkage and how lon…
Matched conditions: DIFFERENTIATED THYROID CANCER
Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC